Journal of Cutaneous Immunology and Allergy

Original Research

Published on 06 May 2026

Real-world effectiveness and safety of tildrakizumab in Japanese patients with psoriasis: a single-center 52-week observational study

Daisuke Watabe
Kanako Tsunoda
Akemi Hamabata
Maki Goto
Wakako Yoshioka
Hiroo Amano

doi 10.3389/jcia.2026.16442

Brief Research Report

Published on 28 Apr 2026

Deficiency of inflammatory caspases attenuates IL-33–mediated dermatitis

Mami Amaki
Teruasa Murata
Nobuo Kanazawa
Yasutomo Imai

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2026.16358

Review

Published on 30 Mar 2026

Immune perturbation in arsenic-induced adverse health effects and cancers

Chien-Hui Hong
Sebastian Yu
Shu-Li Wang
Hsin-Su Yu
Chih-Hung Lee

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2026.16386

Case Report

Published on 20 Mar 2026

Case Report: A case with Xeroderma pigmentosum type F manifested a mild phenotype due to a deep intronic variant of the ERCC4 gene

Mei Tochigi
Yuko Takamiya
Megumi Morita
Kazushi Anzawa
Akira Shimizu
Sumihito Togi
Hiroki Ura
Yo Niida

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2026.16180

Original Research

Published on 23 Feb 2026

The epidemiological and clinical association between primary focal hyperhidrosis and various skin disease in Japanese patients: outpatient questionnaire analysis

Keiji Kosaka
Akihiko Uchiyama
Mai Ishikawa
Sei-Ichiro Motegi

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2026.15800

Correction

Published on 20 Feb 2026

Corrigendum: The possible effectiveness of difamilast in improving barrier dysfunction in patients with atopic dermatitis and in mouse model

Akihiko Uchiyama
Bayarmaa Taivanbat
Keiji Kosaka
Mai Ishikawa
Akihito Uehara
Masatoshi Shimaoka
Keiichiro Ryuzaki
Sei-Ichiro Motegi

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2026.16328

Letter to the Editor

Published on 05 Feb 2026

Exacerbation of hand rash after dupilumab initiation in a child with atopic dermatitis who was able to continue treatment

Kanoko Kono
Takashi Sakai
Yutaka Hatano

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2026.16078

Letter to the Editor

Published on 22 Jan 2026

Coexistence of lichenoid and psoriasiform eruptions following PD-1 blockade immunotherapy

Tatsuya Ogawa
Shin Matsumoto
Keiji Tabuchi
Toshifumi Nomura

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2026.15453

8 Publications

volumes

Real-world effectiveness and safety of tildrakizumab in Japanese patients with psoriasis: a single-center 52-week observational study

Deficiency of inflammatory caspases attenuates IL-33–mediated dermatitis

Immune perturbation in arsenic-induced adverse health effects and cancers

Case Report: A case with Xeroderma pigmentosum type F manifested a mild phenotype due to a deep intronic variant of the ERCC4 gene

The epidemiological and clinical association between primary focal hyperhidrosis and various skin disease in Japanese patients: outpatient questionnaire analysis

Corrigendum: The possible effectiveness of difamilast in improving barrier dysfunction in patients with atopic dermatitis and in mouse model

Exacerbation of hand rash after dupilumab initiation in a child with atopic dermatitis who was able to continue treatment

Coexistence of lichenoid and psoriasiform eruptions following PD-1 blockade immunotherapy